美罗培南
微生物学
头孢菌素
医学
生物
抗生素
抗生素耐药性
作者
Dimitrios Basoulis,Aikaterini Gkoufa,Elpida Mastrogianni,Angeliki Pantazatou,Ioannis Deliolanis,Anastasia Rigatou,Αmalia Karapanou,Sofia Zerva,Maria N. Gamaletsou,Michael Samarkos,Nikolaos V. Sipsas
摘要
Ceftolozane/tazobactam is a viable alternative to meropenem for the treatment of ESBL BSIs. Prospective studies are needed to confirm these findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI